Endometrial cancer after endometrial ablation: a systematic review.
Endometrial Neoplasms
Endometrium
Surgical Procedures, Operative
Journal
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
ISSN: 1525-1438
Titre abrégé: Int J Gynecol Cancer
Pays: England
ID NLM: 9111626
Informations de publication
Date de publication:
05 12 2022
05 12 2022
Historique:
pubmed:
15
11
2022
medline:
7
1
2023
entrez:
14
11
2022
Statut:
epublish
Résumé
To investigate whether a previously performed endometrial ablation is associated with the development and diagnosis of endometrial cancer. First, a systematic review was performed of the articles reporting the incidence of endometrial cancer in patients treated with endometrial ablation. Second, a systematic review was performed to identify all individual cases of endometrial cancer after ablation to evaluate presenting symptoms, diagnostic work-up, potential risk factors, and the type and stage of the endometrial cancer. A systematic search was performed, using Medline, EMBASE, and the Cochrane Library databases, from inception through February 24, 2022. Based on 11 included studies, the incidence of endometrial cancer in a population of 29 102 patients with a prior endometrial ablation ranged from 0.0% to 1.6%.A total of 38 cases of endometrial cancer after ablation were identified. In 71% of cases (17 of 24 cases), vaginal bleeding was the first presenting symptom. With transvaginal ultrasound it was possible to identify and measure the endometrial thickness in eight cases. Endometrium sampling was successful in 16 of 18 described cases (89%). In 18 of 20 cases (90%) pathologic examination showed early-stage endometrioid adenocarcinoma (International Federation of Gynecology and Obstetrics stage I). Previous endometrial ablation is not associated with the development of endometrial cancer. Diagnostic work-up is not impeded by previous endometrial ablation. In addition, endometrial cancers after endometrial ablation are not detected at an advanced stage.
Identifiants
pubmed: 36375895
pii: ijgc-2022-003866
doi: 10.1136/ijgc-2022-003866
doi:
Types de publication
Systematic Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1555-1560Informations de copyright
© IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: MYB reports financial relationships with Gynesonics (device reduction in clinical trials), outside the submitted work. MYB is a member of the advisory board of Hologic. The remaining authors declare no conflicts of interest.